116 related articles for article (PubMed ID: 9121181)
61. The role of prostate specific antigen measurement in the detection and management of prostate cancer.
Nash AF; Melezinek I
Endocr Relat Cancer; 2000 Mar; 7(1):37-51. PubMed ID: 10808195
[TBL] [Abstract][Full Text] [Related]
62. Prostate-specific antigen. Its discovery and biochemical characteristics.
Sokoll LJ; Chan DW
Urol Clin North Am; 1997 May; 24(2):253-9. PubMed ID: 9126221
[TBL] [Abstract][Full Text] [Related]
63. Physical activity releases prostate-specific antigen (PSA) from the prostate gland into blood and increases serum PSA concentrations.
Oremek GM; Seiffert UB
Clin Chem; 1996 May; 42(5):691-5. PubMed ID: 8653893
[TBL] [Abstract][Full Text] [Related]
64. A Non-Enzymatic and Label-Free Fluorescence Bioassay for Ultrasensitive Detection of PSA.
Sun Y; Wang C; Zhang H; Zhang Y; Zhang G
Molecules; 2019 Feb; 24(5):. PubMed ID: 30813571
[TBL] [Abstract][Full Text] [Related]
65. The clinical importance of free prostate-specific antigen (PSA).
Stenman UH; Leinonen J; Zhang WM; Finne P; Wu P
Curr Opin Urol; 1998 Sep; 8(5):393-9. PubMed ID: 17039018
[TBL] [Abstract][Full Text] [Related]
66. Four no more: The 'PSA cutoff era' is over.
Jones JS; Klein E
Cleve Clin J Med; 2008 Jan; 75(1):30-2. PubMed ID: 18236726
[No Abstract] [Full Text] [Related]
67. Does the reflexive measurement of free PSA have a role in a tertiary cancer centre?
Allard C; Yip P; Blasutig I; Hersey K; Fleshner N
Can Urol Assoc J; 2010 Oct; 4(5):317-20. PubMed ID: 20944800
[TBL] [Abstract][Full Text] [Related]
68. Information regarding prostate-specific antigen (PSA) testing was recently published in the New England Journal of Medicine.
McCarthy DH
Prog Transplant; 2001 Sep; 11(3):162. PubMed ID: 11949456
[No Abstract] [Full Text] [Related]
69. Diagnosing prostate cancer at a curable stage means providing PSA tests to asymptomatic patients.
Booth CM; Chinegwundoh F; Allen S; Van Poppel H
BMJ; 2022 Jul; 378():o1714. PubMed ID: 35820680
[No Abstract] [Full Text] [Related]
70. How should prostate specific antigen be interpreted?
Atan A; Güzel Ö
Turk J Urol; 2013 Sep; 39(3):188-93. PubMed ID: 26328106
[TBL] [Abstract][Full Text] [Related]
71. Editorial comment to "The value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0-10.0 ng/mL) in Nigeria" and Reply by authors.
Elabbady A; Ezenwa EV
Arab J Urol; 2012 Dec; 10(4):400-1. PubMed ID: 26558057
[No Abstract] [Full Text] [Related]
72. Evolving Role of Pro-PSA as a New Serum Marker for the Early Detection of Prostate Cancer.
Khan MA; Partin AW
Rev Urol; 2002; 4(4):198-200. PubMed ID: 16985683
[No Abstract] [Full Text] [Related]
73. Reflexive ordering of percent free PSA in patients: Do we need to ask the question?
Lattouf JB
Can Urol Assoc J; 2010 Oct; 4(5):321. PubMed ID: 20944801
[No Abstract] [Full Text] [Related]
74. Screening for prostate cancer: a study on the free and total prostate specific antigen.
Mediu R; Rama A; Mediu N
Discoveries (Craiova); 2021; 9(4):e139. PubMed ID: 35359347
[TBL] [Abstract][Full Text] [Related]
75. A predictive model for prostate cancer incorporating PSA molecular forms and age.
Oto J; Fernández-Pardo Á; Royo M; Hervás D; Martos L; Vera-Donoso CD; Martínez M; Heeb MJ; España F; Medina P; Navarro S
Sci Rep; 2020 Feb; 10(1):2463. PubMed ID: 32051423
[TBL] [Abstract][Full Text] [Related]
76. Brief report: Free prostate-specific antigen test utilization. Consistency with guidelines.
Jackson BR; Roberts WL
J Gen Intern Med; 2005 Sep; 20(9):859-61. PubMed ID: 16117757
[TBL] [Abstract][Full Text] [Related]
77. Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels.
Hoffman RM; Clanon DL; Littenberg B; Frank JJ; Peirce JC
J Gen Intern Med; 2000 Oct; 15(10):739-48. PubMed ID: 11089718
[TBL] [Abstract][Full Text] [Related]
78. Impact of assay parameters on the accuracy of free PSA test: source and stability of calibrator, calibration curve fitting, and level of total PSA in the serum.
Liu GH; Wu JT
J Clin Lab Anal; 1998; 12(5):304-9. PubMed ID: 9773963
[TBL] [Abstract][Full Text] [Related]
79. Advantages of replacing the total PSA assay with the assay for PSA-alpha 1-antichymotrypsin complex for the screening and management of prostate cancer.
Wu JT; Liu GH
J Clin Lab Anal; 1998; 12(1):32-40. PubMed ID: 9484667
[TBL] [Abstract][Full Text] [Related]
80. Monitoring percent free PSA in serial specimens: improvement of test specificity, early detection, and identification of occult tumors.
Wu JT; Liu GH; Zhang P; Stephenson RA
J Clin Lab Anal; 1998; 12(1):26-31. PubMed ID: 9484666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
